BioSig Technologies Completes Share Exchange with Streamex

BioSig Technologies ( (BSGM) ) has provided an update.

On May 28, 2025, BioSig Technologies completed a share exchange transaction with Streamex Exchange Corporation, resulting in executive leadership changes and the formation of a company focused on real-world asset tokenization. Henry McPhie, co-founder of Streamex, was appointed as the new CEO of the combined company, while Morgan Lekstrom became the Chairman of the Board. This strategic move positions the company to capitalize on the $142.851 trillion global commodity market by bringing commodities on-chain, enhancing liquidity and efficiency in the industry.

The most recent analyst rating on (BSGM) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on BioSig Technologies stock, see the BSGM Stock Forecast page.

Spark’s Take on BSGM Stock

According to Spark, TipRanks’ AI Analyst, BSGM is a Underperform.

BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.

To see Spark’s full report on BSGM stock, click here.

More about BioSig Technologies

BioSig Technologies is a company focused on leveraging advanced technology to transform healthcare and other sectors. Streamex Exchange Corporation, now a wholly-owned subsidiary of BioSig, specializes in the tokenization of real-world assets, particularly in the commodities space, aiming to bring commodity markets on-chain with innovative financial technologies.

Average Trading Volume: 503,382

Technical Sentiment Signal: Buy

Current Market Cap: $137.8M

See more data about BSGM stock on TipRanks’ Stock Analysis page.